Press Releases for the Psychedelics Industry

Psychedelics News

Press Releases

27 Jan 2021

Mindset Pharma Announces Listing on the Frankfurt Stock Exchange

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

27 Jan 2021

NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer

Vancouver, British Columbia–(Newsfile Corp....

By Microdose

Press Releases

26 Jan 2021

REPEAT – Pure Extracts Enters Into Biomass Purchase Agreements To Support Oil Extract Production

VANCOUVER, British Columbia, Jan....

By Microdose

Press Releases

26 Jan 2021

Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US

ATLANTA, Jan....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

26 Jan 2021

Psyched Wellness Included in First Psychedelic Exchange Traded Fund

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

26 Jan 2021

Havn Life Sciences Enters Definitive Agreement to Acquire Strategic Manufacturing & Packaging Facility for its Retail Division

The acquisition is intended to vertically integrate the Company’s retail manufacturing capabilities to support the growth of its nutraceutical division and deliver unique products to consumers....

By Microdose

Press Releases

25 Jan 2021

Psyched Wellness to Present at Inaugural KCSA Psychedelics Investor Conference

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

25 Jan 2021

PSYC Enters Joint Venture Partnership with Minerco, Inc.

PSYC Sets Sights on Expanding Its Digital Platform Within the Emerging Sector of Medicinal Psychedelics LAS VEGAS, NV, Jan....

By Microdose

Press Releases

25 Jan 2021

Ehave, Inc. Utilizes Artificial Intelligence and Machine Learning for Big Data Management in Mental Healthcare

MIAMI, Jan....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result